Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Will an artificial pancreas be a gamechanger for type 1 diabetes?

In December 2019, French start-up Diabeloop announced they had secured €31m Series B funding (a record for a European therapeutic AI company). Its device, which has been described as an 'artificial pancreas', uses artificial intelligence to automate and personalise treatment for patients with type 1 diabetes. Abi Millar finds out more.


Go Top